Imen vaccine alborz

Imen Vaccine Alborz is a prominent Iranian biotechnology company focused on the development and production of advanced viral vaccines. The company is best known for launching Cervira, the first domestically manufactured bivalent human papillomavirus (HPV) vaccine, which targets HPV types 16 and 18 to prevent cervical cancer. Based in the Alborz province, the firm operates as a knowledge-based entity, utilizing recombinant DNA technology and large-scale cell culture for its manufacturing processes. Their product portfolio aims to address significant public health challenges in the region, including Hepatitis B and seasonal influenza. By establishing local production capabilities, Imen Vaccine Alborz significantly contributes to Iran's strategic goal of pharmaceutical self-sufficiency and reduces the economic burden of importing high-cost biologics. The company maintains rigorous quality standards to ensure its products meet international safety and efficacy benchmarks.